Skip to main content
Erschienen in: Current Infectious Disease Reports 3/2013

01.06.2013 | Pediatric Infectious Diseases (I Brook, Section Editor)

Penicillin Failure in the Treatment of Streptococcal Pharyngo-Tonsillitis

verfasst von: Itzhak Brook

Erschienen in: Current Infectious Disease Reports | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

The inadequate penetration of penicillins into the tonsillar tissues and tonsillar surface fluid and microbiologic interactions between Group A beta-hemolytic streptococci (GABHS) and other pharyngo-tonsillar bacterial flora can account for their failure in eradicating GABHS pharyngo-tonsillitis (PT). These interactions include the presence of beta-lactamase producing bacteria (BLPB) that “shield” GABHS from penicillins, the absence of bacteria that interfere with the growth of GABHS, and the coaggregation between GABHS and Moraxella catarrhalis. In the treatment of acute tonsillitis, the use of cephalosporins can overcome these interactions by eradicating aerobic BLPB, while preserving the potentially interfering organisms and eliminating GABHS. In treatment of recurrent and chronic PT, the administration of clindamycin or amoxicillin-clavulanatecan eradicates both aerobic and anaerobic BLPB, as well as GABHS.
Literatur
1.
Zurück zum Zitat Pichichero ME, Casey JR. The evidence base for cephalosporin superiority over penicillin in streptococcal pharyngitis. Diagn Microbiol Infect Dis. 2007;57(Supplement):S39–45. Pichichero ME, Casey JR. The evidence base for cephalosporin superiority over penicillin in streptococcal pharyngitis. Diagn Microbiol Infect Dis. 2007;57(Supplement):S39–45.
2.
Zurück zum Zitat Kaplan EL, Chatwal GS, Rohde M. Reduced ability of penicillin to eradicate ingested Group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis. 2006;43:1398–406.PubMedCrossRef Kaplan EL, Chatwal GS, Rohde M. Reduced ability of penicillin to eradicate ingested Group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis. 2006;43:1398–406.PubMedCrossRef
3.
Zurück zum Zitat Brook I. Role of beta-lactamase–producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis. 1984;6:601–7.PubMedCrossRef Brook I. Role of beta-lactamase–producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis. 1984;6:601–7.PubMedCrossRef
4.
Zurück zum Zitat Lafontaine ER, Wall D, Vanlerberg SL, Donabedian H, Sledjeski DD. Moraxella catarrhalis coaggregates with Streptococcus pyogenes and modulates interactions of S pyogenes with human epithelial cells. Infect Immun. 2004;72:6689–93.PubMedCrossRef Lafontaine ER, Wall D, Vanlerberg SL, Donabedian H, Sledjeski DD. Moraxella catarrhalis coaggregates with Streptococcus pyogenes and modulates interactions of S pyogenes with human epithelial cells. Infect Immun. 2004;72:6689–93.PubMedCrossRef
5.
Zurück zum Zitat Grahn E, Holm SE. Bacterial interference in the throat flora during a pharyngo- tonsillitis outbreak in an apartment house area. Zbl Bakl Hyg A. 1983;256:72–9. Grahn E, Holm SE. Bacterial interference in the throat flora during a pharyngo- tonsillitis outbreak in an apartment house area. Zbl Bakl Hyg A. 1983;256:72–9.
6.
Zurück zum Zitat Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg. 2005;133(1):139–46. Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg. 2005;133(1):139–46.
7.
Zurück zum Zitat Neeman R, Keller N, Barzilai A, Korenman Z, Sela S. Prevalence of internalization-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet. 1998;352:1974–7.PubMedCrossRef Neeman R, Keller N, Barzilai A, Korenman Z, Sela S. Prevalence of internalization-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet. 1998;352:1974–7.PubMedCrossRef
8.
Zurück zum Zitat Stjernquist-Desatnik A, Samuelsson P, Walder M. Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis. J Laryngol Otol. 1993;107:309–12.PubMedCrossRef Stjernquist-Desatnik A, Samuelsson P, Walder M. Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis. J Laryngol Otol. 1993;107:309–12.PubMedCrossRef
9.
Zurück zum Zitat Marouni MJ, Barzilai A, Keller N, Rubinstein E, Sela S. Intracellular survival of persistent Group A streptococci in cultured epithelial cells. Int J Med Microbiol. 2004;294:27–33.PubMedCrossRef Marouni MJ, Barzilai A, Keller N, Rubinstein E, Sela S. Intracellular survival of persistent Group A streptococci in cultured epithelial cells. Int J Med Microbiol. 2004;294:27–33.PubMedCrossRef
10.
Zurück zum Zitat Orrling A, Kamme C, Stjernquist-Desatnik A. Penicillin V, loracarbef and clindamycin in tonsillar surface fluid during acute Group A streptococcal pharyngotonsillitis. Scand J Infect Dis. 2005;37:429–35.PubMedCrossRef Orrling A, Kamme C, Stjernquist-Desatnik A. Penicillin V, loracarbef and clindamycin in tonsillar surface fluid during acute Group A streptococcal pharyngotonsillitis. Scand J Infect Dis. 2005;37:429–35.PubMedCrossRef
11.
Zurück zum Zitat Brook I. Emergence and persistence of beta-lactamase–producing bacteria in the oropharynx following penicillin treatment. Arch Otolaryngol Head Neck Surg. 1988;114:667–70.PubMedCrossRef Brook I. Emergence and persistence of beta-lactamase–producing bacteria in the oropharynx following penicillin treatment. Arch Otolaryngol Head Neck Surg. 1988;114:667–70.PubMedCrossRef
12.
Zurück zum Zitat Brook I. Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate Group A strepharyngo-tonsillitisococci. Pediatr Infect Dis. 1985;4:491–5.PubMedCrossRef Brook I. Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate Group A strepharyngo-tonsillitisococci. Pediatr Infect Dis. 1985;4:491–5.PubMedCrossRef
13.
Zurück zum Zitat Brook I, Gober AE. Failure to eradicate streptococci and beta-lactamase producing bacteria. Acta Paediatr. 2008;96:193–5.CrossRef Brook I, Gober AE. Failure to eradicate streptococci and beta-lactamase producing bacteria. Acta Paediatr. 2008;96:193–5.CrossRef
14.
Zurück zum Zitat Brook I, Yocum P, Friedman EM. Aerobic and anaerobic bacteria in tonsils of children with recurrent tonsillitis. Ann Otol Rhinol Laryngol. 1981;90:261–3.PubMed Brook I, Yocum P, Friedman EM. Aerobic and anaerobic bacteria in tonsils of children with recurrent tonsillitis. Ann Otol Rhinol Laryngol. 1981;90:261–3.PubMed
15.
Zurück zum Zitat Taylan I, Ozcan I, Mumcuoğlu I, Baran I, Murat Özcan K, Akdoğan O, et al. Comparison of the surface and core bacteria in tonsillar and adenoid tissue with beta-lactamase production. Indian J Otolaryngol Head Neck Surg. 2011;63:223–8.PubMedCrossRef Taylan I, Ozcan I, Mumcuoğlu I, Baran I, Murat Özcan K, Akdoğan O, et al. Comparison of the surface and core bacteria in tonsillar and adenoid tissue with beta-lactamase production. Indian J Otolaryngol Head Neck Surg. 2011;63:223–8.PubMedCrossRef
16.
Zurück zum Zitat Reilly S, Timmis P, Beeden AG, Willis AT. Possible role of the anaerobe in tonsillitis. J Clin Pathol. 1981;34:542–7.PubMedCrossRef Reilly S, Timmis P, Beeden AG, Willis AT. Possible role of the anaerobe in tonsillitis. J Clin Pathol. 1981;34:542–7.PubMedCrossRef
17.
Zurück zum Zitat Tuner K, Nord CE. Beta-lactamase–producing anaerobic bacteria in recurrent tonsillitis. J Antimicrob Chemother. 1982;10(suppl A):153–6.PubMedCrossRef Tuner K, Nord CE. Beta-lactamase–producing anaerobic bacteria in recurrent tonsillitis. J Antimicrob Chemother. 1982;10(suppl A):153–6.PubMedCrossRef
18.
Zurück zum Zitat Chagollan J, Macias JR, Gil JS. Flora indigena de las amigdales. Invest Med Int. 1984;11:36–9. Chagollan J, Macias JR, Gil JS. Flora indigena de las amigdales. Invest Med Int. 1984;11:36–9.
19.
Zurück zum Zitat Kielmovitch IH, Keleti G, Bluestone CD, Wald ER, Gonzales C. Microbiology of obstructive tonsillar hypertrophy and recurrent tonsillitis. Arch Otolaryngol Head Neck Surg. 1989;115:721–5.PubMedCrossRef Kielmovitch IH, Keleti G, Bluestone CD, Wald ER, Gonzales C. Microbiology of obstructive tonsillar hypertrophy and recurrent tonsillitis. Arch Otolaryngol Head Neck Surg. 1989;115:721–5.PubMedCrossRef
20.
Zurück zum Zitat Brook I, Yocum P, Foote Jr PA. Changes in the core tonsillar bacteriology of recurrent tonsillitis, 1977–1993. Clin Infect Dis. 1995;21:171–6.PubMedCrossRef Brook I, Yocum P, Foote Jr PA. Changes in the core tonsillar bacteriology of recurrent tonsillitis, 1977–1993. Clin Infect Dis. 1995;21:171–6.PubMedCrossRef
21.
Zurück zum Zitat Brook I, Yocum P. Quantitative measurement of beta-lactamase level in tonsils of children with recurrent tonsillitis. Acta Otolaryngol Scand. 1984;98:446–60. Brook I, Yocum P. Quantitative measurement of beta-lactamase level in tonsils of children with recurrent tonsillitis. Acta Otolaryngol Scand. 1984;98:446–60.
22.
Zurück zum Zitat Brook I. Beta-lactamase-producing bacteria and their role in infection. Rev Med Microbiol. 2005;16:91–9.CrossRef Brook I. Beta-lactamase-producing bacteria and their role in infection. Rev Med Microbiol. 2005;16:91–9.CrossRef
23.
Zurück zum Zitat Brook I. Treatment of patients with acute recurrent tonsillitis due to Group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxicillin/clavulanate potassium. J Antimicrob Chemother. 1989;24:227–33.PubMedCrossRef Brook I. Treatment of patients with acute recurrent tonsillitis due to Group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxicillin/clavulanate potassium. J Antimicrob Chemother. 1989;24:227–33.PubMedCrossRef
24.
Zurück zum Zitat Kaplan EL, Johnson DR. Eradication of Group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr. 1988;113:400–3.PubMedCrossRef Kaplan EL, Johnson DR. Eradication of Group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr. 1988;113:400–3.PubMedCrossRef
25.
Zurück zum Zitat Holm S, Henning C, Grahn E, Lomberg H, Staley H. Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. The Swedish Study Group. Scand J Infect Dis. 1995;27:221–8.PubMedCrossRef Holm S, Henning C, Grahn E, Lomberg H, Staley H. Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. The Swedish Study Group. Scand J Infect Dis. 1995;27:221–8.PubMedCrossRef
26.
Zurück zum Zitat Holm SE, Roos K, Stromberg A. A randomized study of treatment of streptococcal pharyngotonsillitis with cefadroxil or phenoxymethylpenicillin (penicillin V). Pediatr Infect Dis J. 1991;10:S68–71.PubMedCrossRef Holm SE, Roos K, Stromberg A. A randomized study of treatment of streptococcal pharyngotonsillitis with cefadroxil or phenoxymethylpenicillin (penicillin V). Pediatr Infect Dis J. 1991;10:S68–71.PubMedCrossRef
27.
Zurück zum Zitat Socransky SS, Manganiello SD. The oral microflora of man from birth to senility. J Periodontol. 1971;42:485–96.PubMedCrossRef Socransky SS, Manganiello SD. The oral microflora of man from birth to senility. J Periodontol. 1971;42:485–96.PubMedCrossRef
28.
Zurück zum Zitat Brook I, Gober AE. Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate Group A streptococcal pharyngotonsillitis. Arch Otolaryngol Head Neck Surg. 1995;121:1405–9.PubMedCrossRef Brook I, Gober AE. Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate Group A streptococcal pharyngotonsillitis. Arch Otolaryngol Head Neck Surg. 1995;121:1405–9.PubMedCrossRef
29.
Zurück zum Zitat Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg. 2005;133:139–46.PubMedCrossRef Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg. 2005;133:139–46.PubMedCrossRef
30.
Zurück zum Zitat Brook I, Gober AE. Bacterial interference by aerobic and anaerobic bacteria in children with recurrent Group A beta-hemolytic streptococcal tonsillitis. Arch Otolaryngol Head Neck Surg. 1999;125:552–4.PubMed Brook I, Gober AE. Bacterial interference by aerobic and anaerobic bacteria in children with recurrent Group A beta-hemolytic streptococcal tonsillitis. Arch Otolaryngol Head Neck Surg. 1999;125:552–4.PubMed
31.
Zurück zum Zitat Roos K, Grahn E, Holm SE, Johansson H, Lind L. Interfering alpha- streptococci as a protection against recurrent streptococcal tonsillitis in children. Int J Pediatr Otol. 1993;25:141–8.CrossRef Roos K, Grahn E, Holm SE, Johansson H, Lind L. Interfering alpha- streptococci as a protection against recurrent streptococcal tonsillitis in children. Int J Pediatr Otol. 1993;25:141–8.CrossRef
32.
Zurück zum Zitat Roos K, Holm SE, Grahn E, Lind L. Alpha-strepharyngo-tonsillitisococci as supplementary treatment of recurrent pharyngo-tonsillitis: a randomized placebo-controlled study. Scand J Infect Dis. 1993;25:31–5.PubMed Roos K, Holm SE, Grahn E, Lind L. Alpha-strepharyngo-tonsillitisococci as supplementary treatment of recurrent pharyngo-tonsillitis: a randomized placebo-controlled study. Scand J Infect Dis. 1993;25:31–5.PubMed
33.
Zurück zum Zitat Roos K, Holm SE, Grahn-Hakansson E, Lagergren L. Recolonization with selected alpha- streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis – a randomized placebo-controlled multicentre study. Scand J Infect Dis. 1996;28:459–62.PubMedCrossRef Roos K, Holm SE, Grahn-Hakansson E, Lagergren L. Recolonization with selected alpha- streptococci for prophylaxis of recurrent streptococcal pharyngotonsillitis – a randomized placebo-controlled multicentre study. Scand J Infect Dis. 1996;28:459–62.PubMedCrossRef
34.
Zurück zum Zitat Falck G, Grahn-Håkansson E, Holm SE, Roos K, Lagergren L. Tolerance and efficacy of interfering alpha- streptococcus in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study. Acta Otolaryngol (Stockh). 1999;119:944–8.CrossRef Falck G, Grahn-Håkansson E, Holm SE, Roos K, Lagergren L. Tolerance and efficacy of interfering alpha- streptococcus in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study. Acta Otolaryngol (Stockh). 1999;119:944–8.CrossRef
35.
Zurück zum Zitat Brook I, Gober AE. Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxicillin-clavulanate. J Med Microbiol. 2005;54:553–6.PubMedCrossRef Brook I, Gober AE. Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxicillin-clavulanate. J Med Microbiol. 2005;54:553–6.PubMedCrossRef
36.
Zurück zum Zitat Brook I, Gillmore JD. Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with Group A beta-hemolytic streptococcus. Antimicrob Agents Chemother. 1993;37:1452–5.PubMedCrossRef Brook I, Gillmore JD. Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with Group A beta-hemolytic streptococcus. Antimicrob Agents Chemother. 1993;37:1452–5.PubMedCrossRef
37.
Zurück zum Zitat Brook I, Gober E. Recovery of interfering and beta-lactamase-producing bacteria from group A beta-haemolytic streptococci carriers and non-carriers. J Med Microbiol. 2006;55:1741–4.PubMedCrossRef Brook I, Gober E. Recovery of interfering and beta-lactamase-producing bacteria from group A beta-haemolytic streptococci carriers and non-carriers. J Med Microbiol. 2006;55:1741–4.PubMedCrossRef
38.
Zurück zum Zitat Brook I, Gillmore JD. Enhancement of growth of Group A beta-hemolytic streptococcus in mixed infections with aerobic and anaerobic bacteria. Clin Microbiol Infect. 1996;1:179–82.PubMedCrossRef Brook I, Gillmore JD. Enhancement of growth of Group A beta-hemolytic streptococcus in mixed infections with aerobic and anaerobic bacteria. Clin Microbiol Infect. 1996;1:179–82.PubMedCrossRef
39.
Zurück zum Zitat Brook I, Gober AE. Increased recovery of Moraxella catarrhalis and Haemophillus influenzae in association with Group A beta-hemolytic streptococcus in healthy children and those with pharyngo-tonsillitis. J Med Microb. 2006;55:989–92.CrossRef Brook I, Gober AE. Increased recovery of Moraxella catarrhalis and Haemophillus influenzae in association with Group A beta-hemolytic streptococcus in healthy children and those with pharyngo-tonsillitis. J Med Microb. 2006;55:989–92.CrossRef
40.
Zurück zum Zitat Casey JR, Pichichero ME. Meta-analysis of cephalosporins versus penicillin for treatment of Group A streptococcal tonsillopharyngitis in adults. Clin Infect Dis. 2004;38:1526–34.PubMedCrossRef Casey JR, Pichichero ME. Meta-analysis of cephalosporins versus penicillin for treatment of Group A streptococcal tonsillopharyngitis in adults. Clin Infect Dis. 2004;38:1526–34.PubMedCrossRef
41.
Zurück zum Zitat Pichichero ME. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it? Pediatr Infect Dis J. 1993;12:268–74.PubMedCrossRef Pichichero ME. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it? Pediatr Infect Dis J. 1993;12:268–74.PubMedCrossRef
42.
Zurück zum Zitat Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Practice guidelines for the diagnosis and management of Group A streptococcal pharyngitis. 2012 update of the Infectious Diseases Society of America. Clin Infect Dis. 2012;55:1279–82.PubMedCrossRef Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G, et al. Practice guidelines for the diagnosis and management of Group A streptococcal pharyngitis. 2012 update of the Infectious Diseases Society of America. Clin Infect Dis. 2012;55:1279–82.PubMedCrossRef
43.
Zurück zum Zitat Brook I, Hirokawa R. Treatment of patients with a history of recurrent tonsillitis due to Group A beta-hemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin and clindamycin. Clin Pediatr. 1985;24:331–6.CrossRef Brook I, Hirokawa R. Treatment of patients with a history of recurrent tonsillitis due to Group A beta-hemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin and clindamycin. Clin Pediatr. 1985;24:331–6.CrossRef
44.
Zurück zum Zitat Casey JR, Pichichero ME. Meta-analysis of short course antibiotic treatment for Group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 2005;24:909–17.PubMedCrossRef Casey JR, Pichichero ME. Meta-analysis of short course antibiotic treatment for Group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 2005;24:909–17.PubMedCrossRef
45.
Zurück zum Zitat Brook I, Gober AE. Rate of eradication of Group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir. Int J Pediatr Otolaryngol. 2009;757–9. Brook I, Gober AE. Rate of eradication of Group A beta-hemolytic streptococci in children with pharyngo-tonsillitis by amoxicillin and cefdinir. Int J Pediatr Otolaryngol. 2009;757–9.
46.
Zurück zum Zitat Brook I, Foote PA. Efficacy of penicillin versus cefdinir in eradication of Group A streptococcal pharyngo-tonsillitis and tonsillar flora. Antimicrob Agents Chemother. 2005;49:4787–8.PubMedCrossRef Brook I, Foote PA. Efficacy of penicillin versus cefdinir in eradication of Group A streptococcal pharyngo-tonsillitis and tonsillar flora. Antimicrob Agents Chemother. 2005;49:4787–8.PubMedCrossRef
47.
Zurück zum Zitat Breese BB, Disney FA, Talpey WB. Beta-hemolytic streptococcal illness: comparison of lincomycin, ampicillin, and potassium penicillin in treatment. Am J Dis Child. 1966;112:21–7.PubMed Breese BB, Disney FA, Talpey WB. Beta-hemolytic streptococcal illness: comparison of lincomycin, ampicillin, and potassium penicillin in treatment. Am J Dis Child. 1966;112:21–7.PubMed
48.
Zurück zum Zitat Breese BB, Disney FA, Talpey WB, Green J. Beta-hemolytic streptococcal infection: comparison of penicillin and lincomycin in the treatment of recurrent infections of the carrier state. Am J Dis Child. 1969;117:14–527. Breese BB, Disney FA, Talpey WB, Green J. Beta-hemolytic streptococcal infection: comparison of penicillin and lincomycin in the treatment of recurrent infections of the carrier state. Am J Dis Child. 1969;117:14–527.
49.
Zurück zum Zitat Randolph MF, DeHaan RM. A comparison of lincomycin and pencillin in the treatment of Group A streptococcal infection. Del Med J. 1969;41:51–62.PubMed Randolph MF, DeHaan RM. A comparison of lincomycin and pencillin in the treatment of Group A streptococcal infection. Del Med J. 1969;41:51–62.PubMed
50.
Zurück zum Zitat Howie VM, Plousard JH. Treatment of group A streptococcal pharyngitis in children: comparison of lincomycin and penicillin G given orally and benzathine penicillin G given intramuscularly. Am J Dis Child. 1971;121:477–80.PubMed Howie VM, Plousard JH. Treatment of group A streptococcal pharyngitis in children: comparison of lincomycin and penicillin G given orally and benzathine penicillin G given intramuscularly. Am J Dis Child. 1971;121:477–80.PubMed
51.
Zurück zum Zitat Randolph MF, Redys JJ, Hibbard EW. Streptococcal pharyngitis: III. Streptococcal recurrence rates following therapy with penicillin or with clindamycin (7-chlorolincomycin). Del Med J. 1970;42:87–92.PubMed Randolph MF, Redys JJ, Hibbard EW. Streptococcal pharyngitis: III. Streptococcal recurrence rates following therapy with penicillin or with clindamycin (7-chlorolincomycin). Del Med J. 1970;42:87–92.PubMed
52.
Zurück zum Zitat Stillerman M, Isenberg HD, Facklam RR. Streptococcal pharyngitis therapy: comparison of clindamycin palmitate and potassium phenoxymethyl penicillin. Antimicrob Agents Chemother. 1973;4:514–20.PubMedCrossRef Stillerman M, Isenberg HD, Facklam RR. Streptococcal pharyngitis therapy: comparison of clindamycin palmitate and potassium phenoxymethyl penicillin. Antimicrob Agents Chemother. 1973;4:514–20.PubMedCrossRef
53.
Zurück zum Zitat Chaudhary S, Bilinsky SA, Hennessy JL, Soler SM, Wallace SE, Schacht CM, et al. Penicillin V and rifampin for the treatment of Group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy. J Pediatr. 1985;106:481–6.PubMedCrossRef Chaudhary S, Bilinsky SA, Hennessy JL, Soler SM, Wallace SE, Schacht CM, et al. Penicillin V and rifampin for the treatment of Group A streptococcal pharyngitis: a randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy. J Pediatr. 1985;106:481–6.PubMedCrossRef
54.
Zurück zum Zitat Smith TD, Huskins WC, Kim KS, Kaplan EL. Efficacy of beta-lactamase-resistant penicillin and influence of penicillin in eradicating streptococci for the pharynx after failure of penicillin therapy for Group A streptococcal pharyngitis. J Pediatr. 1987;110:777–82.PubMedCrossRef Smith TD, Huskins WC, Kim KS, Kaplan EL. Efficacy of beta-lactamase-resistant penicillin and influence of penicillin in eradicating streptococci for the pharynx after failure of penicillin therapy for Group A streptococcal pharyngitis. J Pediatr. 1987;110:777–82.PubMedCrossRef
55.
Zurück zum Zitat Orrling A, Stjernquist-Desatnik A, Schalen C, Kamme C. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment. Scand J Infect Dis. 1994;26:535–41.PubMedCrossRef Orrling A, Stjernquist-Desatnik A, Schalen C, Kamme C. Clindamycin in persisting streptococcal pharyngotonsillitis after penicillin treatment. Scand J Infect Dis. 1994;26:535–41.PubMedCrossRef
56.
Zurück zum Zitat Mahakit P, Vicente JG, Butt DI, Angeli G, Bansal S, Zambrano D. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years. Clin Ther. 2006;28:99–109.PubMedCrossRef Mahakit P, Vicente JG, Butt DI, Angeli G, Bansal S, Zambrano D. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years. Clin Ther. 2006;28:99–109.PubMedCrossRef
Metadaten
Titel
Penicillin Failure in the Treatment of Streptococcal Pharyngo-Tonsillitis
verfasst von
Itzhak Brook
Publikationsdatum
01.06.2013
Verlag
Current Science Inc.
Erschienen in
Current Infectious Disease Reports / Ausgabe 3/2013
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-013-0338-0

Weitere Artikel der Ausgabe 3/2013

Current Infectious Disease Reports 3/2013 Zur Ausgabe

Pediatric Infectious Diseases (I Brook, Section Editor)

Reducing Central Line Infections in Pediatric and Neonatal Patients

PEDIATRIC INFECTIOUS DISEASES (I BROOK, SECTION EDITOR)

Long-Term Sequelae of Childhood Bacterial Meningitis

Tropical, Travel and Emerging Infections (L Chen, Section Editor)

Pediatric Travel Medicine: Challenges for the Primary Care and Travel Medicine Specialist

Pediatric Infectious Diseases (I Brook, Section Editor)

Treatment and Prevention of Rotavirus Infection in Children

Pediatric Infectious Diseases (I Brook, Section Editor)

Rheumatic Fever and Post-Group A Streptococcal Arthritis in Children

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.